CHRISTINE LOVLY
Division Chief of Thoracic Medical Oncology
City of Hope
Christine M. Lovly, MD, PhD, FASCO, is an internationally recognized lung cancer expert and physician‑scientist specializing in precision medicine. Her research focuses on defining the molecular drivers of lung cancer and uncovering mechanisms of resistance to targeted therapies, particularly in tumors with EGFR and ALK alterations. By seamlessly integrating laboratory discovery with clinical application, she has established a true bench‑to‑bedside approach that informs biomarker‑driven clinical trials and highly individualized treatment strategies. She is a leading voice in the use of liquid biopsy and circulating tumor DNA to monitor disease evolution and guide therapy, and has played a pivotal role in advancing these tools toward routine clinical practice.
Through her leadership, City of Hope is expanding its multidisciplinary thoracic oncology program, increasing access to advanced genomic testing and innovative clinical trials for patients across Southern California and beyond.
